Cite
MLA Citation
P. Borchmann et al.. “EBEACOPP WITH OR WITHOUT RITUXIMAB IN INTERIM‐PET‐POSITIVE ADVANCED‐STAGE HODGKIN LYMPHOMA: UPDATED RESULTS OF THE INTERNATIONAL, RANDOMIZED PHASE 3 GHSG HD18 TRIAL.” Hematological oncology, vol. 35, n.d., p. 65. http://access.bl.uk/ark:/81055/vdc_100047421627.0x000030